Deborah M. Messemer's Net Worth

$3.99 Million

Estimate Recalculated Nov 5, 2024 07:11PM EST

Who is Deborah M. Messemer

Deborah M. Messemer has an estimated net worth of $3.99 Million. This is based on reported shares across multiple companies, which include PayPal Holdings, Inc., TPG Inc., and Allogene Therapeutics, Inc..

SEC CIK

Deborah M. Messemer's CIK is 0001754424

Past Insider Trading and Trends

2022 was Deborah M. Messemer's most active year for acquiring shares with 4 total transactions. Deborah M. Messemer's most active month to acquire stocks was the month of May. 2024 was Deborah M. Messemer's most active year for disposing of shares, totalling 4 transactions. Deborah M. Messemer's most active month to dispose stocks was the month of January. 2024 saw Deborah M. Messemer paying a total of $0.00 for 130,964 shares, this is the most they've acquired in one year. In 2024 Deborah M. Messemer cashed out on 33,542 shares for a total of $786,417.08, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PayPal Holdings, Inc.

Investor
Updated May 24, 2024
Form 4
-24.04%
-4.42K
$61.65
-$272.62K
May 24, 2024
13.98K
Sale
May 24
Form 4
31.64%
4.42K
May 23, 2024
18.40K
Grant
May 22
Form 4
46.71%
4.45K
May 26, 2023
13.98K
Grant
May 24
Form 4
48.57%
3.11K
Jun 03, 2022
9.53K
Grant
Jun 02
Form 4
19.65%
1.05K
May 27, 2021
6.41K
Grant
May 26
Form 4
52.98%
1.86K
May 22, 2020
5.36K
Grant
May 21
Form 4
231.41%
2.45K
May 24, 2019
3.50K
Grant
May 22
Form 3/A
Jan 25, 2019
Form 3/A
Jan 25, 2019
Form 4
1.06K
Jan 18, 2019
1.06K
Grant
Jan 16
Form 3
Jan 18, 2019
1.06K
Showing 11 results

TPG Inc.

Investor
Updated Jul 17, 2024
Form 4
-2.76%
-497.00
$46.55
-$190.33K
Jul 17, 2024
17.54K
Sale
ScheduledJul 15 - Jul 17
Form 4
-26.16%
-6.39K
$43.97
-$280.98K
Mar 01, 2024
18.03K
Sale
Feb 28
Form 4
26.47%
5.11K
Jul 18, 2023
24.42K
Grant
Jul 15
Form 4
89.89%
9.14K
Jul 19, 2022
19.31K
Grant
Jul 15
Form 4
10.17K
Jan 13, 2022
10.17K
Grant
Jan 13
Form 3
Jan 13, 2022
Showing 6 results

Allogene Therapeutics, Inc.

Investor
Updated Jun 20, 2024
Form 4
-10.05%
-18.64K
$2.28
-$42.49K
Jun 20, 2024
166.77K
Sale
Jun 18
Form 4
196.86%
122.95K
Jun 07, 2024
185.41K
Grant
Jun 05
Form 4
-22.99%
-18.64K
$2.70
-$50.32K
Dec 20, 2023
62.46K
Sale
Dec 18
Form 4
1,140.95%
74.56K
Jun 15, 2023
81.10K
Grant
Jun 13
Form 4
71.07K
Jun 17, 2022
71.07K
Grant
Jun 15
Form 4
28.02K
Jun 11, 2021
28.02K
Grant
Jun 10
Form 4
16.64K
Jun 09, 2020
16.64K
Grant
Jun 05
Form 4
26.02K
Jun 24, 2019
26.03K
Grant
Jun 06
Form 4
6.54K
Oct 17, 2018
6.54K
Acq/Dis
Oct 15
Form 3
Oct 10, 2018
Showing 10 results